呕吐是一种复杂的反射活动,各种止吐药可通过影响呕吐反射的不同环节而发挥止吐作用。这些机制包括抑制化学感受器、大脑皮质、耳前庭器官或直接作用于呕吐中枢。因此,在选择用药时应根据具体情况加以考虑。
通常情况下,预防性使用止吐药物的效果优于治疗性使用,尤其是在处理晕动症、放射病或化疗引起的呕吐时更为明显。对于妊娠呕吐,则需谨慎选用止吐药,一般仅推荐苯海拉明和茶苯海拉明等药物,在剧烈呕吐时才可考虑使用吩噻嗪类。
常用的止吐药物包括:
催吐药主要用于促使急性中毒患者将胃中的毒物呕吐出来。其催吐作用主要通过兴奋中枢催吐化学感受器或刺激消化道反射性地兴奋呕吐中枢来实现,如使用阿扑吗啡。然而,目前更常采用洗胃法替代催吐药物的使用。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
马罗皮坦柠檬酸盐水合物 | maropitant citrate monohydrate | 359875-09-5 | C6H8O7*C32H40N2O*H2O |
|
阿瑞吡坦 | aprepitant | 170729-80-3 | C23H21F7N4O3 |
|
萘二磺酸乙乳胆铵 | Aclatonium Napadisilate | 55077-30-0 | C10H6O6S2*2C10H20NO4 |
|
莫沙必利 | mosapride | 112885-41-3 | C21H25ClFN3O3 |
|
美托哌丙嗪 | metopimazine | 14008-44-7 | C22H27N3O3S2 |
|
硫酸铜 | Sulfuric acid copper(2+) salt (1:1), hydrate (8CI,9CI) | 7758-99-8 | CuH4O5S |
|
盐酸阿扎司琼 | Azasetron hydrochloride | 123040-16-4 | C17H20ClN3O3*ClH |
|
盐酸阿扎司琼 | azasetron | 123040-69-7 | C17H20ClN3O3 |
|
盐酸地芬尼多 | diphenidol hydrochloride | 3254-89-5 | C21H27NO*ClH |
|
盐酸去水吗啡 | apomorphine hydrochloride | 314-19-2 | C17H17NO2*ClH |
|
盐酸依托必利 | itopride hydrochloride | 122892-31-3 | C20H26N2O4*ClH |
|
盐酸三甲氧苯酰胺 | trimethobenzamide hydrochloride | 554-92-7 | C21H28N2O5*ClH |
|
枸橼酸莫沙比利 | Mosapride citrate dihydrate | 636582-62-2 | C27H37ClFN3O12 |
|
枸橼酸莫沙必利含结晶水 | 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide 2-Hydroxy-1,2,3-propanetricarboxylate Hydrate | 636582-62-2 | C27H35ClFN3O11 |
|
替加色罗 | tegaserod | 145158-71-0 | C16H23N5O |
|
曲美苄胺 | Trimethobenzamide | 138-56-7 | C21H28N2O5 |
|
地芬尼多 | difenidol | 972-02-1 | C21H27NO |
|
吐根碱 | cephaeline | 483-17-0 | C28H38N2O4 |
|
匹哌马嗪 | pipamazine | 84-04-8 | C21H24ClN3OS |
|
克立波必利 | clebopride | 55905-53-8 | C20H24ClN3O2 |
|
伊托必利 | itopride | 122898-67-3 | C20H26N2O4 |
|
乙巯匹拉嗪 | thiethylperazine | 1420-55-9 | C22H29N3S2 |
|
三氯叔丁醇 | 1,1,1-trichloro-2-methyl-2-propanol | 57-15-8 | C4H7Cl3O |
|
—— | 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2alpha,6alpha,8alpha,9abeta)-, monomethanesulfonate | 115956-13-3 | C20H24N2O6S |
|
—— | Dolasetron mesylate hydrate | 115956-13-3 | C20H26N2O7S |
|
—— | (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydron;dichloride;hydrate | 314-19-2 | C34H38Cl2N2O5 |
|
—— | methanesulfonic acid;[(7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | 115956-13-3 | C20H24N2O6S |
|
—— | Tropisetron | 89565-68-4 | C17H20N2O2 |
|
—— | 2-methyl-1-(9-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazol-3-yl)imidazol-3-ium chloride dihydrate | 103639-04-9 | C18H19N3O*ClH*2H2O |
|
—— | Dolasetron methanesulfonate | 878143-33-0 | C20H24N2O6S |
|
—— | Aclatonium napadisilate | 55077-30-0 | C30H46N2O14S2 |
|
—— | (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;chloride | 41372-20-7 | C17H17ClNO2- |
|
—— | Granisertron hydrochloride | 107007-99-8 | C18H25ClN4O |
|
—— | 1-Methyl-N-((1R,3R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-YL)-1H-indazole-3-carboxamide | 109889-09-0 | C18H24N4O |
|
—— | Fosaprepitant Dimeglumine | 265121-04-8 | C37H56F7N6O16P |
|
—— | cephaeline | 483-17-0 | C28H38N2O4 |
|
—— | granisetron | 109889-09-0 | C18H24N4O |
|
—— | Granisetron hydrochloride | 107007-99-8 | C18H24N4O*ClH |
|
—— | [1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-7-yl)indazole-3-carboxamide] | 109889-09-0 | C18H24N4O |
|
—— | trans-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one base | 115956-12-2 | C19H20N2O3 |
|
—— | [(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | 115956-12-2 | C19H20N2O3 |
|
—— | [(7S)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | 115956-12-2 | C19H20N2O3 |
|
—— | [(7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | 115956-12-2 | C19H20N2O3 |
|
—— | 1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester,exo- | 89565-68-4 | C17H20N2O2 |
|
—— | Fosaprepitant dimeglumine | 265121-04-8 | 2C7H17NO5*C23H22F7N4O6P |
|